Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Journal of Clinical Medicine|November 26, 2022
Contemporary Management of Postoperative Crohn's Disease after Ileocolonic ResectionJurij Hanzel, David Drobne
Scandinavian Journal of Gastroenterology|December 8, 2025
High persistence and efficacy of ustekinumab as a first-line biological therapy in inflammatory bowel disease: a real-world cohort studyŽiva Šubic, David Drobne, Gregor Novak
Antioxidants (Basel, Switzerland)|October 29, 2025
Oxidative Stress-Related Biomarkers in Inflammatory Bowel Disease: Dual Tools for Remission Assessment and Prediction of Treatment OutcomeArmando Tratenšek, Iztok Grabnar, David Drobne, et al.
European Journal of Gastroenterology & Hepatology|March 11, 2026
Applicator preferences for subcutaneous biologics in inflammatory bowel disease: influence on patient satisfaction and willingness to switch treatmentDušica Prodanova, Ana Janeva, David Drobne, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 21, 2025
Quantifying fibrosis in inflammatory bowel diseases - contribution of digital pathologyMiha Jerala, Li Chen, David Drobne, et al.
Pharmaceuticals (Basel, Switzerland)|March 28, 2026
Strategies to Overcome Hematocrit and Volume Bias in Dried Blood Spot AnalysisPanagiotis-Dimitrios Mingas, Matjaž Cirar, Iztok Grabnar, et al.
Pharmaceuticals (Basel, Switzerland)|September 27, 2025
Development, Validation and Application of the Dried Blood Spot Analysis Method for the Determination of Ustekinumab in Patients with Inflammatory Bowel DiseasePanagiotis-Dimitrios Mingas, Jurij Aguiar Zdovc, Iztok Grabnar, et al.
Pageof 5